Efficacy and safety of #obeldesivir in low-risk, non-hospitalised #patients with #COVID19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study
Obeldesivir, a drug orally given with antiviral properties, is also used against Covid-19. Now it has been tested on non-human primates and seems to give between 80 and 100 percent protection against lethal Ebola virus infection, when treatment is started 24 hours after exposure. Whether it also can protect humans is not clear yet. See http://www.neat-news.com/2025/03/53.php. #Ebola#obeldesivir
Study: Gilead antiviral drug shows promise as a treatment for Ebola Sudan
A new study suggests the antiviral drug obeldesivir may be effective in curing Ebola Sudan infections, for which there are currently no approved vaccines or treatments.